Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrzej Bienczak"'
Autor:
Moshe Ben-Shoshan, Bulent Enis Sekerel, Petra Staubach-Renz, Montserrat Alvaro-Lozano, Marcus Maurer, Anton Drollmann, Andrzej Bienczak, Miriam Porter, Tian Liu, Alis Burciu, Thomas Severin
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB179
Autor:
Paolo Denti, Helen McIlleron, Cissy Kityo, Adrian Cook, Adeniyi Olagunju, Andrew Owen, David M. Burger, Lubbe Wiesner, Veronica Mulenga, Andrzej Bienczak, Addy Kekitiinwa, A. Sarah Walker, Diana M. Gibb
Publikováno v:
British Journal of Clinical Pharmacology. 82:185-198
AIM: To characterise the efavirenz steady-state pharmacokinetics in African children using model-based approach, quantifying demographic and genotypic effects on the drug's disposition, and conduct simulations allowing prediction of optimised doses o
Autor:
AS Walker, Andrzej Bienczak, Helen McIlleron, Adrian Cook, Cissy Kityo, Paolo Denti, Lubbe Wiesner, Veronica Mulenga, Diana M. Gibb, Addy Kekitiinwa, David M. Burger
Publikováno v:
Aids, 31, 7, pp. 905-915
Aids, 31, 905-915
Aids, 31, 905-915
Contains fulltext : 169950.pdf (Publisher’s version ) (Closed access) BACKGROUND: Nevirapine is the only nonnucleoside reverse transcriptase inhibitor currently available as a paediatric fixed-dose-combination tablet and is widely used in African c
Autor:
Saïk Urien, Naïm Bouazza, Paolo Denti, Tim R. Cressey, Andrzej Bienczak, Jean-Marc Treluyer, David M. Burger, Marc Lallemant, Helen McIlleron, Frantz Foissac, Martina Penazzato, Edmund V. Capparelli
Publikováno v:
Journal of Antimicrobial Chemotherapy, 72, 490-495
Journal of Antimicrobial Chemotherapy, 72, 2, pp. 490-495
Journal of Antimicrobial Chemotherapy, 72, 2, pp. 490-495
Item does not contain fulltext BACKGROUND: Child-friendly, low-cost, solid, oral fixed-dose combinations (FDCs) of efavirenz with lamivudine and abacavir are urgently needed to improve clinical management and drug adherence for children. METHODS: Dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9010bc7c6f3cc0afb837051ae05d7ce
http://hdl.handle.net/2066/169771
http://hdl.handle.net/2066/169771
Autor:
Paolo Denti, Andrzej Bienczak, Catherine Orrell, Gary Maartens, David R. Bangsberg, Robin Wood, Karen Cohen
Publikováno v:
International journal of antimicrobial agents. 47(6)
The therapeutic range for efavirenz plasma concentrations is unclear and some studies found no correlation with viral non-suppression. Efavirenz concentrations are variable, driven in part by polymorphisms in CYP2B6 . We hypothesised that efavirenz m
Autor:
Karolina A. Langowska, Przemyslaw Reszka, Rafał Hałasa, Agnieszka Stencel, Andrzej Bienczak, Władysław Werel, Martin Michaelis, Patrick J. Bednarski, Franciszek Sączewski
Publikováno v:
European Journal of Medicinal Chemistry. 43:1847-1857
Eighteen new 2,6-disubstituted acrylonitriles and two new (benzimidazol-1-yl)-acetamide derivatives were prepared and screened for antibacterial and cytotoxic activities on 12 human cancer cell lines. Based on the lead structure 2-(benzimidazol-2-yl)
Autor:
Rafał Hałasa, Patrick J. Bednarski, Przemyslaw Reszka, Elzbieta Pomarnacka, Ewa Dziemidowicz-Borys, Władysław Werel, Andrzej Bienczak
Publikováno v:
European Journal of Medicinal Chemistry. 41:633-639
Two series of 1-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)-4-arylsemicarbazides 6-17 and 2-arylamino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazines 18-26 were prepared in order to evaluate their biological activity. Compounds 6 a
Autor:
Patrick J. Bednarski, Ewa Dziemidowicz-Borys, Rafał Hałasa, Władysław Werel, Elzbieta Pomarnacka, Andrzej Bienczak, Przemyslaw Reszka
Publikováno v:
ChemInform. 37
Two series of 1-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)-4-arylsemicarbazides 6-17 and 2-arylamino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazines 18-26 were prepared in order to evaluate their biological activity. Compounds 6 a